varenicline use was associated with significant improvements in the four-week carbon-monoxide-confirmed continuous quit rate (44.2% at weeks 9-12 compared with bupropion (29.7%) and placebo (17.7% ...
The adjusted odds of abstinence in users of varenicline were 3.83 (95% CI = 1.88–7.77) times higher compared with users of NRT Rx. Conclusions Varenicline use with minimal professional support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback